Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
HALO holding history
Halozyme Therapeutics, Inc. in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HALO overviewAll 13F holders of HALOFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,658
- Value
- $834.2K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,658 | $834.2K | <0.1% | +455+4.5% | Added | Holders |
| Q1 2026 | 10,203 | $659.4K | <0.1% | +10,203 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −4,149−100.0% | Sold out | Holders |
| Q3 2024 | 4,149 | $237.5K | <0.1% | +3,837+1,229.8% | Added | Holders |
| Q2 2024 | 312 | $16.3K | <0.1% | +312 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −15,017−100.0% | Sold out | Holders |
| Q4 2022 | 15,017 | $854.5K | <0.1% | −1,960−11.5% | Reduced | Holders |
| Q3 2022 | 16,977 | $671.0K | <0.1% | −96−0.6% | Reduced | Holders |
| Q2 2022 | 17,073 | $751.0K | <0.1% | −3,025−15.1% | Reduced | Holders |
| Q1 2022 | 20,098 | $802.0K | <0.1% | −153−0.8% | Reduced | Holders |
| Q4 2021 | 20,251 | $814.0K | <0.1% | +34+0.2% | Added | Holders |
| Q3 2021 | 20,217 | $822.0K | <0.1% | +765+3.9% | Added | Holders |
| Q2 2021 | 19,452 | $883.0K | <0.1% | −1,751−8.3% | Reduced | Holders |
| Q1 2021 | 21,203 | $884.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.